Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

24.32 +0.44 (+1.84%)

Official Closing Price Updated: 4:10 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

5 Must-Read Analyst Questions From Pfizer’s Q1 Earnings Call

May 12, 2026

Pfizer’s first quarter results reflected continued momentum in its core portfolio, with management attributing growth to strong performance in recently launc...

Via StockStory

Topics Earnings

Is This a Sign Pfizer's Aggressive Growth Strategy Is Paying Off? ↗

May 11, 2026

Pfizer's acquired and recently launched products generated strong growth last quarter.

Via The Motley Fool

Topics Intellectual Property

BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly

May 11, 2026

Via Investor Brand Network

3 Unprofitable Stocks That Fall Short

May 11, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

Pfizer Inc. (NYSE:PFE) Tops Q1 2026 Estimates Amid Strong Non-COVID Growth ↗

May 05, 2026

Via Chartmill

The Next Generation of the GLP-1 Revolution Is Already Underway

May 11, 2026

From BioMedWire

Via GlobeNewswire

Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers? ↗

May 09, 2026

Pfizer is an innovative pharmaceutical giant that investors have given up on, which is an opportunity if you think long-term.

Via The Motley Fool

Topics Intellectual Property

3 Healthcare Stocks Every Retiree Should Consider ↗

May 08, 2026

If you are trying to generate income in retirement, these three high-yield healthcare stocks could be the perfect fit for you.

Via The Motley Fool

Topics Intellectual Property Retirement

Got $5,000 to Invest in a Volatile Market? Here's Exactly Where I'd Put It. ↗

May 08, 2026

Look for names that tend to trade independently of the overall market, and don't be afraid to achieve some income growth.

Via The Motley Fool

Topics Economy

What Are Horizontal Mergers and Acquisitions?

May 08, 2026

Via BusinesNews Wire

Topics Economy

GoodRx (GDRX) Q1 2026 Earnings Call Transcript ↗

May 08, 2026

GoodRx (GDRX) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There. ↗

May 08, 2026

The competition is far behind.

Via The Motley Fool

Forget Eli Lilly: These 2 Stocks Have More Upside ↗

May 07, 2026

Eli Lilly has a lofty valuation thanks to its strong GLP-1 growth, but don't count out these two competitors.

Via The Motley Fool

What's going on in today's session: S&P500 most active stocks ↗

May 07, 2026

Via Chartmill

Zoetis (NYSE:ZTS) Misses Q1 CY2026 Revenue Estimates, Stock Drops 13%

May 07, 2026

Animal health company Zoetis (NYSE:ZTS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales only rose 1.9% year on year to $2.26 billion. The com...

Via StockStory

Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue

May 07, 2026

Medication company Viatris (NASDAQ:VTRS) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 8.1% year on year to $3.52 bil...

Via StockStory

Topics Artificial Intelligence

Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics ↗

May 07, 2026

Is Pfizer a yield trap? No way.

Via The Motley Fool

Topics Artificial Intelligence Earnings Intellectual Property

History Suggests These 3 Stocks Are Due for a Major Rebound ↗

May 06, 2026

Investors often move like lemmings in the short term, giving long-term investors an opportunity to buy great companies.

Via The Motley Fool

Topics Economy Intellectual Property

Novavax (NVAX) Q1 2026 Earnings Transcript ↗

May 06, 2026

Novavax (NVAX) Q1 2026 Earnings Transcript

Via The Motley Fool

Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars

May 06, 2026

Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 79.1% year on year to $139.5 mill...

Via StockStory

PFE Q1 Deep Dive: Oncology, Obesity Pipeline, and Legal Milestones Shape Outlook

May 06, 2026

Global pharmaceutical company Pfizer (NYSE:PFE) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.4% year on year to $14.45 ...

Via StockStory

Topics Intellectual Property

Down as Much as 55% and Still Magnificent: 3 Dividend Stocks Worth Holding for a Lifetime ↗

May 05, 2026

Just because a dividend stock has suffered a significant stumble doesn't mean the setback is permanent. It doesn't even mean its dividend is in jeopardy.

Via The Motley Fool

Pfizer (PFE) Q1 2026 Earnings Transcript ↗

May 05, 2026

Pfizer (PFE) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Intellectual Property

Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗

May 05, 2026

Via Chartmill

Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View ↗

May 05, 2026

Pfizer beats Q1 estimates with revenue growth and strong pipeline progress, extends Vyndamax patent outlook, and backs 2026 guidance.

Via Benzinga

Topics Intellectual Property

Dow Jumps Over 300 Points; Tyson Foods Posts Upbeat Earnings ↗

May 05, 2026

US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.

Via Benzinga

Topics Earnings Stocks

Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skeptics ↗

May 05, 2026

Pfizer delivered better-than-expected sales and profit.

Via Investor's Business Daily

Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q1 CY2026

May 05, 2026

Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q1 CY2026, with sales up 5.4% year on year to $14.45 billion. On th...

Via StockStory

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 05, 2026

From Pfizer Inc.

Via Business Wire

Poets&Quants™ Names Best & Brightest MBAs of 2026

May 05, 2026

May 5, 2026 -- Annual feature celebrates graduating business students for campus impact and professional achievement

Via 24-7 Press Release

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.